Clinical trial
QUality of Sleep Improvement With Evening Topical Therapy for Non-Erosive Gastroesophageal Reflux Disease: Results of a Single-center, Randomized, Double-blind, Placebo-controlled Study (The QUIET Trial)
NCT07700342 is registered in ClinicalTrials.gov with Cellmedis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- QUality of Sleep Improvement With Evening Topical Therapy for Non-Erosive Gastroesophageal Reflux Disease: Results of a Single-center, Randomized, Double-blind, Placebo-controlled Study (The QUIET Trial)
- Lead sponsor
- Cellmedis
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 9, 2026
- Completion date
- September 30, 2026
- Enrollment
- 50 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
gerd (gastroesophageal reflux disease), nocturnal symptoms of gerd, non-erosive gastro-esophageal reflux disease, sleep disorders in gerd